Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Al Ameen Journal of Medical Sciences ; 16(1):80-91, 2023.
Article in English | CAB Abstracts | ID: covidwho-20239476

ABSTRACT

Background: "Covishield" and "Covaxin" were the two vaccines which were approved for emergency use in India. As there is uncertainty regarding these vaccines, this study aimed to estimate the proportion of acceptance of vaccination against COVID-19 in West Bengal;to identify the possible barriers of vaccine acceptance prevalent among the study population and;to find out the association of acceptance of COVID-19 vaccination with the socio-demographic and other predictor variables. Methods: Oobservational study with cross sectional design was conductedon 294 participants in Muchisa, Budge Budge II and Ward No. 81 of Borough 10, Kolkata Municipal Corporation (KMC) selected by Stratified Random Sampling in 2021 using a predesigned, pretested and structured schedule. The statistical analysis was done using Microsoft Office Excel 2007 and Statistical Package for the Social Sciences Version 16.0. The data were explored using Pearson's chi-square test and logistic regression. A p-value of <0.05 was considered significant. Results: The potential acceptance of Covid-19 vaccination was 59.5% with higher adoption in urban population. The most potential barrier in acceptance of vaccine was "fear of side effects". Higher level of education and history of Covid-19 in the locality were associated with higher acceptance of the vaccination in both the urban and rural areas. Conclusion: A study emphasized on the need for mass campaigns and other behavior change communication activities for addressing the myths surrounding the disease and the newer vaccines and hence improving the currently low vaccine acceptance.

2.
Healthline, Journal of Indian Association of Preventive and Social Medicine ; 12(2):33-42, 2021.
Article in English | GIM | ID: covidwho-1727553

ABSTRACT

Introduction: With the rise of COVID-19 pandemic, the health staffs have faced resistance and disrespect by the society. They have been stigmatised unnecessarily that has been resulted from fear and poor knowledge of general population regarding spread of COVID-19 infection. Objective : To estimate the proportion of health care workers who experienced social stigma during COVID-19 pandemic and to determine the association of social stigma with their socio-demographic and other background characteristics. Method: A descriptive type of observational study, cross-sectional in design was carried out among health care workers(HCWs) of a tertiary care hospital in Kolkata during the COVID-19 lockdown period (19th May 2020-20th July 2020) using a pre-designed, pre-tested, structured schedule. By simple random sampling, 422 HCWs were selected and 410 of them had given consent to participate in this study. MS Excel 2010 and SPSS v20.0 were used for data entry and binary logistic regression. Results : About 52.68% had experienced 'Significant Social Stigma', 32.92% experienced 'Insignificant Social Stigma' and only 14.39% had 'no stigma'. Age groups of 25-40 years and mode of transport by hospital vehicle had significant association with social stigma.

3.
American Journal of Plant Sciences ; 12(3):455-475, 2021.
Article in English | CAB Abstracts | ID: covidwho-1365769

ABSTRACT

From the evolution of the mankind, Turmeric has been used in conventional medication. India is in lead for producing, marketing and exporting the Turmeric and its value added products. Curcumalonga (Turmeric) is an Indian rhizomatous medicinal herb from the Zingiberaceae family that is common and widely available across the globe. The components of Turmeric are curcumin, demethoxycurcumin and bisdemethoxycurcumin and these are collectively known as curcuminoids. Curcumin, the active ingredient of Turmeric is generally investigated by the scientific community for its wide range of antioxidant activity, anti-Inflammatory properties and anti-cancer activity, anti-metabolic syndrome activities, neuroprotective activity, antimicrobial effects, anti-arthritis effects, anti-viral effects, anti-asthma and anti-diabetic effects, anti-obesity, cardio and liver toxicity protection activity, anti-depression and anxiety activities. Turmeric has been widely used as a typical household treatment for cough, sore throat, respiratory ailments and could be an effective immunity booster against SARS-CoV-2 therapy during the ongoing pandemic situation. Safety evaluation studies indicate that both turmeric and curcumin are well tolerated at a very high dose without any toxic effects. Thus, turmeric and its constituents have the potential for the development of modern medicine for the treatment of various diseases. So in this review, we describe the various metabolic roles of curcumin and activities for the benefit of human health.

SELECTION OF CITATIONS
SEARCH DETAIL